Fixed combination of linagliptin/metformin in the treatment of type 2 diabetes mellitus

Abstract

The aim of this paper is to summarize state-of-art information concerning this novel fixed combination and to characterize its current position in the treatment of type 2 diabetes.

Keywords

• Diabetes mellitus
• DPP-4 inhibitors
• linagliptin
• metformin
• fixed combination